Physicians' Academy for Cardiovascular Education

Higher event risk with DAPT with potent P2Y12-antagonist than with clopidogrel-based treatment

ESC 2017 - Barcelona

3' education - Aug. 29, 2017


Prof.dr. Clemens von Birgelen - Medisch Spectrum Twente, Enschede, The Netherlands

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: